STAT3 ameliorates truncated tau-induced cognitive deficits

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Proteolytic cleavage of tau by asparagine endopeptidase (AEP) generates tau-N368 fragments implicated in Alzheimer's disease (AD) pathophysiology.
• Truncated tau-induced synaptic dysfunction and memory deficits are not fully understood.
• Signal transducer and activator of transcription-3 (STAT3) is crucial for synaptic plasticity, neuronal survival, and cognitive function.

Purpose of the Study:

• To elucidate the molecular mechanisms by which tau-N368 fragments contribute to cognitive deficits.
• To investigate the role of STAT3 in the pathophysiology of tau-N368-induced neurodegeneration.
• To evaluate STAT3 as a potential therapeutic target for tau-N368-related pathology.

Main Methods:

• Luciferase reporter assays
• Electrophoretic mobility shift assays (EMSA)
• Western blotting
• Immunofluorescence
• Studies in tau-N368 mouse models

Main Results:

• Tau-N368 accumulation inhibits STAT3 activity by preventing its nuclear translocation.
• STAT3 overexpression ameliorates tau-N368-induced synaptic deficits and neuronal loss in mice.
• STAT3 activation in tau-N368 mice increases N-methyl-D-aspartic acid receptor levels and decreases Bcl-2 levels, reversing synaptic damage and cognitive impairment.

Conclusions:

• STAT3 plays a critical role in mitigating neuropathological changes associated with truncated tau.
• STAT3 inhibition is a key mechanism underlying tau-N368-induced synaptic and memory deficits.
• STAT3 represents a promising molecular target for therapeutic intervention in Alzheimer's disease.